Beyond chimerism analysis: methods for tracking a new generation of cell-based medicines

Area of Science:

• * Regenerative Medicine
• * Transplantation Immunology

Background:

• * Chimerism analysis is essential for monitoring patients undergoing hematopoietic stem cell transplantation (HSCT).
• * Current detection techniques include nucleic acid analysis (PCR, NGS), flow cytometry, and multimodal imaging.
• * Advanced therapies necessitate adaptable chimerism detection methods for diverse cell- and gene-based medicines.

Purpose of the Study:

• * To review and analyze the current toolkit of labeling and detection methodologies for chimerism analysis.
• * To discuss the challenges and potential solutions for adapting these methods to novel therapeutic approaches.
• * To highlight the suitability of existing techniques for new cell- and gene-based medicines.

Main Methods:

• * Review of nucleic acid-based techniques (PCR, NGS).
• * Evaluation of cellular phenotype analysis (flow cytometry).
• * Assessment of advanced imaging modalities, including multimodal imaging with labeling agents.

Main Results:

• * Existing chimerism analysis methods are largely suitable for novel cell- and gene-based medicines.
• * Adaptability of current techniques to new routes of administration, target organs, and pathologies is feasible.
• * Potential for evolution and combination of methodologies towards non-invasive, informative approaches.

Conclusions:

• * Current chimerism analysis techniques provide a robust foundation for monitoring advanced therapies.
• * Methodological evolution and integration can lead to more sophisticated, non-invasive patient monitoring.
• * Continued development is key to optimizing chimerism analysis for the future of regenerative medicine.